Related Experiment Video
Updated: May 14, 2026
11:44
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis
Fei-Fei Chen1, Guan Jiang, Kerui Xu
1Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Jiangsu 221002, P.R. China ;
Oncology Letters
|February 20, 2013
Summary
Interferon regulatory factor (IRF)-1 plays a crucial role in suppressing cancer development by regulating cell cycle, apoptosis, and immune responses. Understanding IRF-1's molecular mechanisms offers potential for new cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- Interferon regulatory factor (IRF)-1 is implicated in the regulation of interferon-alpha and beta transcription.
- IRF-1 gene alterations are linked to the development of various human cancers.
- IRF-1 exhibits diverse functions in controlling oncogenesis.
Purpose of the Study:
- To review recent advances in understanding the molecular mechanisms of IRF-1's tumor-suppressive functions.
- To highlight the role of IRF-1 in regulating key cellular processes relevant to cancer.
- To explore the implications of IRF-1's function for cancer susceptibility, progression, and therapeutic strategies.
Main Methods:
- Review of recent scientific literature on IRF-1 and oncogenesis.
- Analysis of molecular mechanisms underlying IRF-1's functions.
- Correlation of IRF-1 activity with clinical observations in human cancers.
Main Results:
- IRF-1 activates target genes involved in cell cycle control, apoptosis, and immune response.
- IRF-1's tumor-suppressive activity is mediated through diverse molecular pathways.
- Evidence suggests IRF-1 plays a significant role in modulating cancer susceptibility and progression.
Conclusions:
- IRF-1 is a critical regulator of oncogenesis with multifaceted roles.
- Understanding IRF-1's molecular mechanisms is vital for cancer research.
- Targeting IRF-1 pathways may offer novel therapeutic avenues for human malignant diseases.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...